Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.

被引：0
|
作者：
Yu, Irene
Cheung, Winson Y.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3576
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.
    Yamanaka H.
    Motohiro T.
    Michiura T.
    Asai A.
    Mori T.
    Hioki K.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (10): : 943 - 948
  • [22] Efficacy of capecitabine vs. infusional 5-FU as neoadjuvant chemoradiotherapy for rectal cancer
    Kocakova, I
    Kubala, E.
    Spurny, V
    Dvorak, J.
    Finek, J.
    Cwiertka, K.
    Prausova, J.
    Hoch, J.
    Vyzula, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 66 - 66
  • [23] Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine after radical gastrectomy for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kwon, H.
    Kim, M.
    Jung, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S303 - S304
  • [24] MITOMYCIN-C (MMC) VS 5-FLUOROURACIL (5-FU), A COMPARISON IN PRIMARY TRABECULECTOMY
    ZIEL, CJ
    JOHNSTONE, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 727 - 727
  • [25] Pharmacoeconomic analysis of treating advanced gastric cancer (AGC) with capecitabine/cisplatin (XP) vs. 5-FU/cisplatin (FP) regimens in an Italian setting
    Garrison, L. P.
    Cirrincione, A.
    Giuliani, G.
    VALUE IN HEALTH, 2007, 10 (03) : A127 - A127
  • [26] Cost of treating advanced gastric cancer (AGC) with capecitabine/cisplatin vs. 5-FU/cisplatin regimens: An economic evaluation from an Italian perspective
    Giuliani, G.
    Falcone, A.
    Cirrincione, A.
    Garrison, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 265 - 265
  • [27] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [28] A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford.
    Pumpalova, Yoanna S.
    Kozak, Margaret M.
    von Eyben, Rie
    Fisher, George A.
    Kunz, Pamela L.
    Chang, Daniel Tandel
    Haraldsdottir, Sigurdis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [29] Phase I trial of cisplatin, infusional 5-FU and irinotecan in advanced gastric cancer.
    Seguru, A
    Fernández-Martos, C
    Aparicio, J
    Campos, JM
    Vicent, J
    Busquier, I
    Molins, C
    Guillem, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 156S - 156S
  • [30] Concomitant chemoradiotherapy using docetaxel, cisplatin, and 5-FU for patients with advanced hypopharyngeal cancer.
    Shiga, K.
    Ogawa, T.
    Kato, K.
    Asada, Y.
    Kobayashi, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345